Clinical Trial Update: Study of Afuresertib Combined With Paclitaxel in Gastric Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the combination of afuresertib and paclitaxel for gastric cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Afuresertib (afuresertib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Cancer | Phase 1 | Status: COMPLETED